img

Global Neostigmine Methylsulfate Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neostigmine Methylsulfate Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

It is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage
Neostigmine Methylsulfate Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neostigmine Methylsulfate Injection market is projected to reach US$ 426.8 million in 2029, increasing from US$ 139 million in 2022, with the CAGR of 17.4% during the period of 2024 to 2029. Demand from Patients with Myasthenia Gravis and Acute Colonic Pseudo-obstruction are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neostigmine Methylsulfate Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


SPH
Jiuxu Pharma
Ronghong Pharma
Xianju Pharma
Pujing Pharma
Dr. Reddy's
Swiss
Daiichi Sankyo
Amneal Pharma
Amphastar Pharmaceuticals
Amring Pharma
BE Pharmaceuticals
Biological E
Caplin Point Laboratories
Exela Pharma
Yifan Pharmaceutical
Segment by Type
0.5Mg/Ml
1Mg/Ml

Segment by Application


Patients with Myasthenia Gravis
Acute Colonic Pseudo-obstruction
Ogway Syndrome
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neostigmine Methylsulfate Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neostigmine Methylsulfate Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neostigmine Methylsulfate Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Neostigmine Methylsulfate Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neostigmine Methylsulfate Injection introduction, etc. Neostigmine Methylsulfate Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Neostigmine Methylsulfate Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Neostigmine Methylsulfate Injection Market Overview
1.1 Neostigmine Methylsulfate Injection Product Overview
1.2 Neostigmine Methylsulfate Injection Market Segment by Type
1.2.1 0.5Mg/Ml
1.2.2 1Mg/Ml
1.3 Global Neostigmine Methylsulfate Injection Market Size by Type
1.3.1 Global Neostigmine Methylsulfate Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Neostigmine Methylsulfate Injection Historic Market Size Review by Type (2018-2024)
1.3.3 Global Neostigmine Methylsulfate Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Neostigmine Methylsulfate Injection Sales Breakdown by Type (2018-2024)
1.4.2 Europe Neostigmine Methylsulfate Injection Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Neostigmine Methylsulfate Injection Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Neostigmine Methylsulfate Injection Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Neostigmine Methylsulfate Injection Sales Breakdown by Type (2018-2024)
2 Global Neostigmine Methylsulfate Injection Market Competition by Company
2.1 Global Top Players by Neostigmine Methylsulfate Injection Sales (2018-2024)
2.2 Global Top Players by Neostigmine Methylsulfate Injection Revenue (2018-2024)
2.3 Global Top Players by Neostigmine Methylsulfate Injection Price (2018-2024)
2.4 Global Top Manufacturers Neostigmine Methylsulfate Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neostigmine Methylsulfate Injection Market Competitive Situation and Trends
2.5.1 Neostigmine Methylsulfate Injection Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Neostigmine Methylsulfate Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neostigmine Methylsulfate Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Neostigmine Methylsulfate Injection Market
2.8 Key Manufacturers Neostigmine Methylsulfate Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Neostigmine Methylsulfate Injection Status and Outlook by Region
3.1 Global Neostigmine Methylsulfate Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Neostigmine Methylsulfate Injection Historic Market Size by Region
3.2.1 Global Neostigmine Methylsulfate Injection Sales in Volume by Region (2018-2024)
3.2.2 Global Neostigmine Methylsulfate Injection Sales in Value by Region (2018-2024)
3.2.3 Global Neostigmine Methylsulfate Injection Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Neostigmine Methylsulfate Injection Forecasted Market Size by Region
3.3.1 Global Neostigmine Methylsulfate Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Neostigmine Methylsulfate Injection Sales in Value by Region (2024-2029)
3.3.3 Global Neostigmine Methylsulfate Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Neostigmine Methylsulfate Injection by Application
4.1 Neostigmine Methylsulfate Injection Market Segment by Application
4.1.1 Patients with Myasthenia Gravis
4.1.2 Acute Colonic Pseudo-obstruction
4.1.3 Ogway Syndrome
4.1.4 Other
4.2 Global Neostigmine Methylsulfate Injection Market Size by Application
4.2.1 Global Neostigmine Methylsulfate Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Neostigmine Methylsulfate Injection Historic Market Size Review by Application (2018-2024)
4.2.3 Global Neostigmine Methylsulfate Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Neostigmine Methylsulfate Injection Sales Breakdown by Application (2018-2024)
4.3.2 Europe Neostigmine Methylsulfate Injection Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Neostigmine Methylsulfate Injection Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Neostigmine Methylsulfate Injection Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Neostigmine Methylsulfate Injection Sales Breakdown by Application (2018-2024)
5 North America Neostigmine Methylsulfate Injection by Country
5.1 North America Neostigmine Methylsulfate Injection Historic Market Size by Country
5.1.1 North America Neostigmine Methylsulfate Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Neostigmine Methylsulfate Injection Sales in Volume by Country (2018-2024)
5.1.3 North America Neostigmine Methylsulfate Injection Sales in Value by Country (2018-2024)
5.2 North America Neostigmine Methylsulfate Injection Forecasted Market Size by Country
5.2.1 North America Neostigmine Methylsulfate Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Neostigmine Methylsulfate Injection Sales in Value by Country (2024-2029)
6 Europe Neostigmine Methylsulfate Injection by Country
6.1 Europe Neostigmine Methylsulfate Injection Historic Market Size by Country
6.1.1 Europe Neostigmine Methylsulfate Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Neostigmine Methylsulfate Injection Sales in Volume by Country (2018-2024)
6.1.3 Europe Neostigmine Methylsulfate Injection Sales in Value by Country (2018-2024)
6.2 Europe Neostigmine Methylsulfate Injection Forecasted Market Size by Country
6.2.1 Europe Neostigmine Methylsulfate Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Neostigmine Methylsulfate Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Neostigmine Methylsulfate Injection by Region
7.1 Asia-Pacific Neostigmine Methylsulfate Injection Historic Market Size by Region
7.1.1 Asia-Pacific Neostigmine Methylsulfate Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Neostigmine Methylsulfate Injection Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Neostigmine Methylsulfate Injection Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Neostigmine Methylsulfate Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Neostigmine Methylsulfate Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Neostigmine Methylsulfate Injection Sales in Value by Region (2024-2029)
8 Latin America Neostigmine Methylsulfate Injection by Country
8.1 Latin America Neostigmine Methylsulfate Injection Historic Market Size by Country
8.1.1 Latin America Neostigmine Methylsulfate Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Neostigmine Methylsulfate Injection Sales in Volume by Country (2018-2024)
8.1.3 Latin America Neostigmine Methylsulfate Injection Sales in Value by Country (2018-2024)
8.2 Latin America Neostigmine Methylsulfate Injection Forecasted Market Size by Country
8.2.1 Latin America Neostigmine Methylsulfate Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Neostigmine Methylsulfate Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Neostigmine Methylsulfate Injection by Country
9.1 Middle East and Africa Neostigmine Methylsulfate Injection Historic Market Size by Country
9.1.1 Middle East and Africa Neostigmine Methylsulfate Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Neostigmine Methylsulfate Injection Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Neostigmine Methylsulfate Injection Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Neostigmine Methylsulfate Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Neostigmine Methylsulfate Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Neostigmine Methylsulfate Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 SPH
10.1.1 SPH Company Information
10.1.2 SPH Introduction and Business Overview
10.1.3 SPH Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.1.4 SPH Neostigmine Methylsulfate Injection Products Offered
10.1.5 SPH Recent Development
10.2 Jiuxu Pharma
10.2.1 Jiuxu Pharma Company Information
10.2.2 Jiuxu Pharma Introduction and Business Overview
10.2.3 Jiuxu Pharma Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Jiuxu Pharma Neostigmine Methylsulfate Injection Products Offered
10.2.5 Jiuxu Pharma Recent Development
10.3 Ronghong Pharma
10.3.1 Ronghong Pharma Company Information
10.3.2 Ronghong Pharma Introduction and Business Overview
10.3.3 Ronghong Pharma Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Ronghong Pharma Neostigmine Methylsulfate Injection Products Offered
10.3.5 Ronghong Pharma Recent Development
10.4 Xianju Pharma
10.4.1 Xianju Pharma Company Information
10.4.2 Xianju Pharma Introduction and Business Overview
10.4.3 Xianju Pharma Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Xianju Pharma Neostigmine Methylsulfate Injection Products Offered
10.4.5 Xianju Pharma Recent Development
10.5 Pujing Pharma
10.5.1 Pujing Pharma Company Information
10.5.2 Pujing Pharma Introduction and Business Overview
10.5.3 Pujing Pharma Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pujing Pharma Neostigmine Methylsulfate Injection Products Offered
10.5.5 Pujing Pharma Recent Development
10.6 Dr. Reddy's
10.6.1 Dr. Reddy's Company Information
10.6.2 Dr. Reddy's Introduction and Business Overview
10.6.3 Dr. Reddy's Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Dr. Reddy's Neostigmine Methylsulfate Injection Products Offered
10.6.5 Dr. Reddy's Recent Development
10.7 Swiss
10.7.1 Swiss Company Information
10.7.2 Swiss Introduction and Business Overview
10.7.3 Swiss Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Swiss Neostigmine Methylsulfate Injection Products Offered
10.7.5 Swiss Recent Development
10.8 Daiichi Sankyo
10.8.1 Daiichi Sankyo Company Information
10.8.2 Daiichi Sankyo Introduction and Business Overview
10.8.3 Daiichi Sankyo Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Daiichi Sankyo Neostigmine Methylsulfate Injection Products Offered
10.8.5 Daiichi Sankyo Recent Development
10.9 Amneal Pharma
10.9.1 Amneal Pharma Company Information
10.9.2 Amneal Pharma Introduction and Business Overview
10.9.3 Amneal Pharma Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Amneal Pharma Neostigmine Methylsulfate Injection Products Offered
10.9.5 Amneal Pharma Recent Development
10.10 Amphastar Pharmaceuticals
10.10.1 Amphastar Pharmaceuticals Company Information
10.10.2 Amphastar Pharmaceuticals Introduction and Business Overview
10.10.3 Amphastar Pharmaceuticals Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Amphastar Pharmaceuticals Neostigmine Methylsulfate Injection Products Offered
10.10.5 Amphastar Pharmaceuticals Recent Development
10.11 Amring Pharma
10.11.1 Amring Pharma Company Information
10.11.2 Amring Pharma Introduction and Business Overview
10.11.3 Amring Pharma Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Amring Pharma Neostigmine Methylsulfate Injection Products Offered
10.11.5 Amring Pharma Recent Development
10.12 BE Pharmaceuticals
10.12.1 BE Pharmaceuticals Company Information
10.12.2 BE Pharmaceuticals Introduction and Business Overview
10.12.3 BE Pharmaceuticals Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.12.4 BE Pharmaceuticals Neostigmine Methylsulfate Injection Products Offered
10.12.5 BE Pharmaceuticals Recent Development
10.13 Biological E
10.13.1 Biological E Company Information
10.13.2 Biological E Introduction and Business Overview
10.13.3 Biological E Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Biological E Neostigmine Methylsulfate Injection Products Offered
10.13.5 Biological E Recent Development
10.14 Caplin Point Laboratories
10.14.1 Caplin Point Laboratories Company Information
10.14.2 Caplin Point Laboratories Introduction and Business Overview
10.14.3 Caplin Point Laboratories Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Caplin Point Laboratories Neostigmine Methylsulfate Injection Products Offered
10.14.5 Caplin Point Laboratories Recent Development
10.15 Exela Pharma
10.15.1 Exela Pharma Company Information
10.15.2 Exela Pharma Introduction and Business Overview
10.15.3 Exela Pharma Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Exela Pharma Neostigmine Methylsulfate Injection Products Offered
10.15.5 Exela Pharma Recent Development
10.16 Yifan Pharmaceutical
10.16.1 Yifan Pharmaceutical Company Information
10.16.2 Yifan Pharmaceutical Introduction and Business Overview
10.16.3 Yifan Pharmaceutical Neostigmine Methylsulfate Injection Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Yifan Pharmaceutical Neostigmine Methylsulfate Injection Products Offered
10.16.5 Yifan Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Neostigmine Methylsulfate Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Neostigmine Methylsulfate Injection Industrial Chain Analysis
11.4 Neostigmine Methylsulfate Injection Market Dynamics
11.4.1 Neostigmine Methylsulfate Injection Industry Trends
11.4.2 Neostigmine Methylsulfate Injection Market Drivers
11.4.3 Neostigmine Methylsulfate Injection Market Challenges
11.4.4 Neostigmine Methylsulfate Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Neostigmine Methylsulfate Injection Distributors
12.3 Neostigmine Methylsulfate Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 0.5Mg/Ml
Table 2. Major Company of 1Mg/Ml
Table 3. Global Neostigmine Methylsulfate Injection Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Neostigmine Methylsulfate Injection Sales by Type (2018-2024) & (Box)
Table 5. Global Neostigmine Methylsulfate Injection Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Neostigmine Methylsulfate Injection Sales by Type (2018-2024) & (US& Million)
Table 7. Global Neostigmine Methylsulfate Injection Market Share in Value by Type (2018-2024)
Table 8. Global Neostigmine Methylsulfate Injection Price by Type (2018-2024) & (US$/Box)
Table 9. Global Neostigmine Methylsulfate Injection Sales by Type (2024-2029) & (Box)
Table 10. Global Neostigmine Methylsulfate Injection Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Neostigmine Methylsulfate Injection Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Neostigmine Methylsulfate Injection Sales Market Share in Value by Type (2024-2029)
Table 13. Global Neostigmine Methylsulfate Injection Price by Type (2024-2029) & (US$/Box)
Table 14. North America Neostigmine Methylsulfate Injection Sales by Type (2018-2024) & (Box)
Table 15. North America Neostigmine Methylsulfate Injection Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Neostigmine Methylsulfate Injection Sales (Box) by Type (2018-2024)
Table 17. Europe Neostigmine Methylsulfate Injection Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Neostigmine Methylsulfate Injection Sales (Box) by Type (2018-2024)
Table 19. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Neostigmine Methylsulfate Injection Sales (Box) by Type (2018-2024)
Table 21. Latin America Neostigmine Methylsulfate Injection Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Neostigmine Methylsulfate Injection Sales (Box) by Type (2018-2024)
Table 23. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Neostigmine Methylsulfate Injection Sales by Company (2018-2024) & (Box)
Table 25. Global Neostigmine Methylsulfate Injection Sales Share by Company (2018-2024)
Table 26. Global Neostigmine Methylsulfate Injection Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Neostigmine Methylsulfate Injection Revenue Share by Company (2018-2024)
Table 28. Global Market Neostigmine Methylsulfate Injection Price by Company (2018-2024) & (US$/Box)
Table 29. Global Neostigmine Methylsulfate Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Neostigmine Methylsulfate Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neostigmine Methylsulfate Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Neostigmine Methylsulfate Injection Market
Table 33. Key Manufacturers Neostigmine Methylsulfate Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Neostigmine Methylsulfate Injection Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Neostigmine Methylsulfate Injection Sales by Region (2018-2024) & (Box)
Table 37. Global Neostigmine Methylsulfate Injection Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Neostigmine Methylsulfate Injection Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Neostigmine Methylsulfate Injection Sales Market Share in Value by Region (2018-2024)
Table 40. Global Neostigmine Methylsulfate Injection Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 41. Global Neostigmine Methylsulfate Injection Sales by Region (2024-2029) & (Box)
Table 42. Global Neostigmine Methylsulfate Injection Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Neostigmine Methylsulfate Injection Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Neostigmine Methylsulfate Injection Sales Market Share in Value by Region (2024-2029)
Table 45. Global Neostigmine Methylsulfate Injection Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2024-2029)
Table 46. Global Neostigmine Methylsulfate Injection Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Neostigmine Methylsulfate Injection Sales by Application (2018-2024) & (Box)
Table 48. Global Neostigmine Methylsulfate Injection Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Neostigmine Methylsulfate Injection Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Neostigmine Methylsulfate Injection Sales Market Share in Value by Application (2018-2024)
Table 51. Global Neostigmine Methylsulfate Injection Price by Application (2018-2024) & (US$/Box)
Table 52. Global Neostigmine Methylsulfate Injection Sales by Application (2024-2029) & (Box)
Table 53. Global Neostigmine Methylsulfate Injection Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Neostigmine Methylsulfate Injection Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Neostigmine Methylsulfate Injection Sales Market Share in Value by Application (2024-2029)
Table 56. Global Neostigmine Methylsulfate Injection Price by Application (2024-2029) & (US$/Box)
Table 57. North America Neostigmine Methylsulfate Injection Sales by Application (2018-2024) (Box)
Table 58. North America Neostigmine Methylsulfate Injection Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Neostigmine Methylsulfate Injection Sales by Application (2018-2024) (Box)
Table 60. Europe Neostigmine Methylsulfate Injection Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Application (2018-2024) (Box)
Table 62. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Neostigmine Methylsulfate Injection Sales by Application (2018-2024) (Box)
Table 64. Latin America Neostigmine Methylsulfate Injection Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Application (2018-2024) (Box)
Table 66. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Neostigmine Methylsulfate Injection Sales by Country (2018-2024) & (Box)
Table 68. North America Neostigmine Methylsulfate Injection Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Neostigmine Methylsulfate Injection Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Neostigmine Methylsulfate Injection Sales Market Share in Value by Country (2018-2024)
Table 71. North America Neostigmine Methylsulfate Injection Sales by Country (2024-2029) & (Box)
Table 72. North America Neostigmine Methylsulfate Injection Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Neostigmine Methylsulfate Injection Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Neostigmine Methylsulfate Injection Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Neostigmine Methylsulfate Injection Sales by Country (2018-2024) & (Box)
Table 76. Europe Neostigmine Methylsulfate Injection Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Neostigmine Methylsulfate Injection Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Neostigmine Methylsulfate Injection Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Neostigmine Methylsulfate Injection Sales by Country (2024-2029) & (Box)
Table 80. Europe Neostigmine Methylsulfate Injection Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Neostigmine Methylsulfate Injection Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Neostigmine Methylsulfate Injection Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Region (2018-2024) & (Box)
Table 84. Asia-Pacific Neostigmine Methylsulfate Injection Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Neostigmine Methylsulfate Injection Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Region (2024-2029) & (Box)
Table 88. Asia-Pacific Neostigmine Methylsulfate Injection Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Neostigmine Methylsulfate Injection Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Neostigmine Methylsulfate Injection Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Neostigmine Methylsulfate Injection Sales by Country (2018-2024) & (Box)
Table 92. Latin America Neostigmine Methylsulfate Injection Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Neostigmine Methylsulfate Injection Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Neostigmine Methylsulfate Injection Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Neostigmine Methylsulfate Injection Sales by Country (2024-2029) & (Box)
Table 96. Latin America Neostigmine Methylsulfate Injection Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Neostigmine Methylsulfate Injection Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Neostigmine Methylsulfate Injection Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Country (2018-2024) & (Box)
Table 100. Middle East and Africa Neostigmine Methylsulfate Injection Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Neostigmine Methylsulfate Injection Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Country (2024-2029) & (Box)
Table 104. Middle East and Africa Neostigmine Methylsulfate Injection Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Neostigmine Methylsulfate Injection Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Neostigmine Methylsulfate Injection Sales Market Share in Value by Country (2024-2029)
Table 107. SPH Company Information
Table 108. SPH Introduction and Business Overview
Table 109. SPH Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 110. SPH Neostigmine Methylsulfate Injection Product
Table 111. SPH Recent Development
Table 112. Jiuxu Pharma Company Information
Table 113. Jiuxu Pharma Introduction and Business Overview
Table 114. Jiuxu Pharma Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 115. Jiuxu Pharma Neostigmine Methylsulfate Injection Product
Table 116. Jiuxu Pharma Recent Development
Table 117. Ronghong Pharma Company Information
Table 118. Ronghong Pharma Introduction and Business Overview
Table 119. Ronghong Pharma Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 120. Ronghong Pharma Neostigmine Methylsulfate Injection Product
Table 121. Ronghong Pharma Recent Development
Table 122. Xianju Pharma Company Information
Table 123. Xianju Pharma Introduction and Business Overview
Table 124. Xianju Pharma Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 125. Xianju Pharma Neostigmine Methylsulfate Injection Product
Table 126. Xianju Pharma Recent Development
Table 127. Pujing Pharma Company Information
Table 128. Pujing Pharma Introduction and Business Overview
Table 129. Pujing Pharma Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 130. Pujing Pharma Neostigmine Methylsulfate Injection Product
Table 131. Pujing Pharma Recent Development
Table 132. Dr. Reddy's Company Information
Table 133. Dr. Reddy's Introduction and Business Overview
Table 134. Dr. Reddy's Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 135. Dr. Reddy's Neostigmine Methylsulfate Injection Product
Table 136. Dr. Reddy's Recent Development
Table 137. Swiss Company Information
Table 138. Swiss Introduction and Business Overview
Table 139. Swiss Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 140. Swiss Neostigmine Methylsulfate Injection Product
Table 141. Swiss Recent Development
Table 142. Daiichi Sankyo Company Information
Table 143. Daiichi Sankyo Introduction and Business Overview
Table 144. Daiichi Sankyo Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 145. Daiichi Sankyo Neostigmine Methylsulfate Injection Product
Table 146. Daiichi Sankyo Recent Development
Table 147. Amneal Pharma Company Information
Table 148. Amneal Pharma Introduction and Business Overview
Table 149. Amneal Pharma Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 150. Amneal Pharma Neostigmine Methylsulfate Injection Product
Table 151. Amneal Pharma Recent Development
Table 152. Amphastar Pharmaceuticals Company Information
Table 153. Amphastar Pharmaceuticals Introduction and Business Overview
Table 154. Amphastar Pharmaceuticals Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 155. Amphastar Pharmaceuticals Neostigmine Methylsulfate Injection Product
Table 156. Amphastar Pharmaceuticals Recent Development
Table 157. Amring Pharma Company Information
Table 158. Amring Pharma Introduction and Business Overview
Table 159. Amring Pharma Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 160. Amring Pharma Neostigmine Methylsulfate Injection Product
Table 161. Amring Pharma Recent Development
Table 162. BE Pharmaceuticals Company Information
Table 163. BE Pharmaceuticals Introduction and Business Overview
Table 164. BE Pharmaceuticals Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 165. BE Pharmaceuticals Neostigmine Methylsulfate Injection Product
Table 166. BE Pharmaceuticals Recent Development
Table 167. Biological E Company Information
Table 168. Biological E Introduction and Business Overview
Table 169. Biological E Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 170. Biological E Neostigmine Methylsulfate Injection Product
Table 171. Biological E Recent Development
Table 172. Caplin Point Laboratories Company Information
Table 173. Caplin Point Laboratories Introduction and Business Overview
Table 174. Caplin Point Laboratories Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 175. Caplin Point Laboratories Neostigmine Methylsulfate Injection Product
Table 176. Caplin Point Laboratories Recent Development
Table 177. Exela Pharma Company Information
Table 178. Exela Pharma Introduction and Business Overview
Table 179. Exela Pharma Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 180. Exela Pharma Neostigmine Methylsulfate Injection Product
Table 181. Exela Pharma Recent Development
Table 182. Yifan Pharmaceutical Company Information
Table 183. Yifan Pharmaceutical Introduction and Business Overview
Table 184. Yifan Pharmaceutical Neostigmine Methylsulfate Injection Sales (Box), Revenue (Million USD), Price (US$/Box) and Gross Margin (2018-2024)
Table 185. Yifan Pharmaceutical Neostigmine Methylsulfate Injection Product
Table 186. Yifan Pharmaceutical Recent Development
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Neostigmine Methylsulfate Injection Market Trends
Table 190. Neostigmine Methylsulfate Injection Market Drivers
Table 191. Neostigmine Methylsulfate Injection Market Challenges
Table 192. Neostigmine Methylsulfate Injection Market Restraints
Table 193. Neostigmine Methylsulfate Injection Distributors List
Table 194. Neostigmine Methylsulfate Injection Downstream Customers
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Neostigmine Methylsulfate Injection Product Picture
Figure 2. Global Neostigmine Methylsulfate Injection Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Neostigmine Methylsulfate Injection Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Neostigmine Methylsulfate Injection Sales Status and Outlook (2018-2029) & (Box)
Figure 5. Product Picture of 0.5Mg/Ml
Figure 6. Global 0.5Mg/Ml Sales YoY Growth (2018-2029) & (Box)
Figure 7. Product Picture of 1Mg/Ml
Figure 8. Global 1Mg/Ml Sales YoY Growth (2018-2029) & (Box)
Figure 9. Global Neostigmine Methylsulfate Injection Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Neostigmine Methylsulfate Injection Sales Market Share by Type in 2022 & 2029
Figure 11. North America Neostigmine Methylsulfate Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Neostigmine Methylsulfate Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Neostigmine Methylsulfate Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Neostigmine Methylsulfate Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Neostigmine Methylsulfate Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Neostigmine Methylsulfate Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Neostigmine Methylsulfate Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Neostigmine Methylsulfate Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Neostigmine Methylsulfate Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Neostigmine Methylsulfate Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Neostigmine Methylsulfate Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Neostigmine Methylsulfate Injection Revenue in 2022
Figure 23. Neostigmine Methylsulfate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Patients with Myasthenia Gravis
Figure 25. Global Patients with Myasthenia Gravis Sales YoY Growth (2018-2029) & (Box)
Figure 26. Product Picture of Acute Colonic Pseudo-obstruction
Figure 27. Global Acute Colonic Pseudo-obstruction Sales YoY Growth (2018-2029) & (Box)
Figure 28. Product Picture of Ogway Syndrome
Figure 29. Global Ogway Syndrome Sales YoY Growth (2018-2029) & (Box)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2029) & (Box)
Figure 32. Global Neostigmine Methylsulfate Injection Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Neostigmine Methylsulfate Injection Sales Market Share by Application in 2022 & 2029
Figure 34. North America Neostigmine Methylsulfate Injection Sales Market Share in Volume by Application in 2022
Figure 35. North America Neostigmine Methylsulfate Injection Sales Market Share in Value by Application in 2022
Figure 36. Europe Neostigmine Methylsulfate Injection Sales Market Share in Volume by Application in 2022
Figure 37. Europe Neostigmine Methylsulfate Injection Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Neostigmine Methylsulfate Injection Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Neostigmine Methylsulfate Injection Sales Market Share in Value by Application in 2022
Figure 40. Latin America Neostigmine Methylsulfate Injection Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Neostigmine Methylsulfate Injection Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Neostigmine Methylsulfate Injection Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Neostigmine Methylsulfate Injection Manufacturing Cost Structure
Figure 45. Neostigmine Methylsulfate Injection Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries